Menu Search
Equities

Enhabit Inc

EHAB:NYQ

Enhabit Inc

Actions
Health CareHealth Care Providers
  • Price (USD)7.89
  • Today's Change-0.03 / -0.38%
  • Shares traded566.78k
  • 1 Year change-20.46%
  • Beta--
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Enhabit Inc's net income fell 99.26% from a loss of 40.40m to a larger loss of 80.50m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 38.74% to 42.21%.
Gross margin48.79%
Net profit margin-11.00%
Operating margin-6.65%
Return on assets-8.28%
Return on equity-18.77%
Return on investment-9.49%
More ▼

Cash flow in USDView more

In 2023, Enhabit Inc increased its cash reserves by 9.56%, or 2.60m. The company earned 48.40m from its operations for a Cash Flow Margin of 4.63%. In addition the company used 5.30m on investing activities and also paid 40.50m in financing cash flows.
Cash flow per share-1.65
Price/Cash flow per share--
Book value per share11.26
Tangible book value per share-8.98
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -98.46%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		31.53
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.